AstraZeneca signs license agreement with China’s CSPC worth up to $2bn
The agreement includes an upfront payment of $100m with the aim to strengthen the UK firm's cardiovascular portfolio.
October 09, 2024
A decision by the Hong Kong Securities and Futures Commission (SFC) to suspend the license of an independent financial advisor, Andrew Barber of Barber Asia Limited, has been upheld by the Securities and Futures Appeals Tribunal (SFAT), although it also reduced the length of his sentence.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].